🇺🇸 FDA
Patent

US 9434758

Non-hormonal steroid modulators of NF-κB for treatment of disease

granted A61KA61K31/57A61K31/573

Quick answer

US patent 9434758 (Non-hormonal steroid modulators of NF-κB for treatment of disease) held by ReveraGen BioPharma, Inc. expires Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ReveraGen BioPharma, Inc.
Grant date
Tue Sep 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K31/57, A61K31/573, A61K31/575, A61P